Boston Scientific (NYSE: BSX) announced that it received CE mark approval for its Embold detachable coil system.
The Embold fibered detachable coil developed by Boston Scientific Corp. to obstruct or reduce the rate of blood flow during therapeutic treatment in the peripheral vasculature, has won U.S. FDA 510(k) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback